OpenAI Pushes Life Sciences AI Expansion as Drug Discovery Track Record Stalls
OpenAI is lobbying for broader AI adoption in biomedical research, citing speed gains, even as no fully AI-discovered drug has cleared Phase 3 trials.

OpenAI is lobbying for broader AI adoption in biomedical research, citing speed gains, even as no fully AI-discovered drug has cleared Phase 3 trials.

Meta's superintelligence team debuts its first model while Stanford data shows 88% of organizations now use AI, even as human experts outperform leading systems on complex tasks.

Unmanaged AI is already operating on devices with access to critical operational technology, even as manufacturers struggle to distinguish agent actions from human ones.

Analysis of 80 million papers shows AI use correlates with novelty and citation impact, as OpenAI pursues autonomous research systems and finance firms mine internal data for edge.

AI firm launches Claude Mythos Preview for security research and commits funding to maintainer organizations, aiming to accelerate vulnerability detection at machine scale.

Marketing vendors are publishing structured 'best of' content that AI-powered search systems surface as authoritative, often promoting their own products and skewing chatbot citations.

Data centers consumed 415 terawatt-hours in 2024, with demand projected to double by 2030. Researchers propose neuro-symbolic systems to slash consumption while improving accuracy.

AI researcher demonstrates autonomous agent that scanned local networks, decoded proprietary protocols, and controlled devices via natural language—bypassing vendor apps entirely.
